Streetbeat News

Products Services

NVO

Novo Nordisk is investing DKK 8.5 billion in a new production facility in Odense, Denmark, marking its first new production site in Denmark this century.

Portfolio Pulse from

December 16, 2024 | 6:45 am

INVA

Basilea Pharmaceutica Ltd has entered into an exclusive agreement with Innoviva Specialty Therapeutics for the commercialization of its antibiotic Zevtera® in the US.

Portfolio Pulse from

December 16, 2024 | 6:30 am

RLFTF

Relief Therapeutics announced positive results from a clinical trial of PKU GOLIKE, a protein substitute for phenylketonuria (PKU) patients. The trial showed improved metabolic control during prolonged fasting, potentially increasing awareness and adoption of PKU GOLIKE.

Portfolio Pulse from

December 16, 2024 | 6:30 am

TTAN

ServiceTitan's stock has risen ~40% since its IPO at $71 per share in mid-December. The company is recommended as a buy due to its strong product platform, effective business model, and balanced growth with positive operating profits.

Portfolio Pulse from

December 16, 2024 | 5:45 am

MRK

Merck's shares have declined, increasing its dividend yield and compressing its valuation, making it an attractive investment opportunity. Keytruda shows strong revenue growth with potential for further approvals. Merck's diverse drug portfolio and robust pipeline support future growth.

Portfolio Pulse from

December 16, 2024 | 5:45 am

TPLC

TPLC is a Biblically Responsible ETF with a 0.52% fee and $272 million in assets. It aims to provide high-quality, less volatile stock exposure but is more volatile than market-cap-weighted benchmarks like IWB. Its profit score is the lowest among selected peers.

Portfolio Pulse from

December 16, 2024 | 5:15 am

AGCO

AGCO is positioned as an attractive investment due to its strong market position and growth potential in the agricultural sector, despite the current down-cycle. Strategic acquisitions and dominant brands, along with a focus on debt reduction, provide a solid foundation for future growth.

Portfolio Pulse from

December 16, 2024 | 5:15 am

INDY

The iShares India 50 ETF (INDY) is recommended as a buy despite India's Manufacturing PMI falling to an 11-month low. The ETF focuses on large-cap growth stocks, particularly in financials and energy, with a P/E ratio of 19.5. The outlook is positive for 2025.

Portfolio Pulse from

December 16, 2024 | 4:30 am

GXYEF

Kevin Kelley, COO of Galaxy Entertainment Group, provided insights into the current state and future outlook of Macao's gaming industry.

Portfolio Pulse from

December 16, 2024 | 4:30 am

BITO

The article discusses the potential of Bitcoin reaching $125k by March 2025, driven by strong ETF inflows, low exchange reserves, and potential regulatory support. It suggests preferring direct Bitcoin holdings or competitors' ETFs over ProShares Bitcoin ETF (BITO) due to lower fees and better tracking.

Portfolio Pulse from

December 16, 2024 | 4:15 am